Novartis loses against Dongkook Pharmaceutical over hyperpituitarism patent
Novartis lost on a trail for injunction against infringement of the hyperpituitarism patent against Dongkook Pharmaceutical.
The 11th Civil Affairs Division, Seoul Central District Court, dismissed the request for injunction against infringement filed by Novartis against Dongkook Pharmaceutical....
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
